The intricacies of the pharmaceutical supply chain may not have been in the mainstream news a few years ago, but recent events kicked this subject to front page news. In 2019, Turing Pharmaceuticals CEO Martin Shkreli was exposed for price gauging lifesaving drugs, thus beaming a spotlight on the pharma supply chain, as Americans became wary of the price of their medications.
In 2020, the Coronavirus disease (COVID-19) ravaged the world and brought pharma’s supply chain into the forefront yet again, likely to remain there forever. These major incidents will leave lasting impressions on the sector.
Read more at Supply & Demand Chain Executive